褪黑素
肿瘤坏死因子α
蛋白激酶B
MAPK/ERK通路
类风湿性关节炎
医学
内分泌学
关节炎
下调和上调
PI3K/AKT/mTOR通路
内科学
炎症
促炎细胞因子
白细胞介素
细胞因子
信号转导
生物
细胞生物学
基因
生物化学
作者
Chien‐Chung Huang,Chen‐Hsiang Chiou,Shan‐Chi Liu,Sung‐Lin Hu,Chen‐Ming Su,Chun‐Hao Tsai,Chih‐Hsin Tang
摘要
The hormone melatonin has many properties, including antioxidant, anti-inflammatory, and immunomodulatory effects. Melatonin has been demonstrated to be beneficial in several inflammatory autoimmune diseases, but its effects in rheumatoid arthritis (RA) remain controversial. We sought to determine how melatonin regulates inflammation in RA. We found that melatonin dose-dependently inhibits tumor necrosis factor-α (TNF-α) and interleukin (IL)-1β expression through the PI3K/AKT, ERK, and NF-κB signaling pathways. We also identified that melatonin inhibits TNF-α and IL-1β production by upregulating miR-3150a-3p expression. Synovial tissue specimens from RA patients and culture of human rheumatoid fibroblast-like synoviocytes confirmed that the MT1 receptor is needed for the anti-inflammatory activities of melatonin. Importantly, melatonin also significantly reduced paw swelling, cartilage degradation, and bone erosion in the collagen-induced arthritis mouse model. Our results indicate that melatonin ameliorates RA by inhibiting TNF-α and IL-1β production through downregulation of the PI3K/AKT, ERK, NF-κB signaling pathways, as well as miR-3150a-3p overexpression. The role of melatonin as an adjuvant treatment in patients with RA deserves further clinical studies.
科研通智能强力驱动
Strongly Powered by AbleSci AI